Lifelong endurance exercise and its relation with coronary atherosclerosis von De Bosscher, R, Dausin, C, Claus, P, Bogaert, J, Dymarkowski, S, Goetschalckx, K, Ghekiere, O, Van De Heyning, CM, Van Herck, P, Paelinck, B, El Addouli, H, La Gerche, A, Herbots, L, Willems, R, Heidbuchel, H, Claessen, G, Claeys, M, Hespel, P, Dresselaers, T, Miljoen, H, Belmans, A, Favere, Kasper, Vermeulen, D, Witvrouwen, I, Hansen, D, Eijnde, Bert Op't, Thijs, D, Vanvoorden, P, Van Soest, S, Master@Heart, Consortium

Volltext

Bimekizumab versus Adalimumab in Plaque Psoriasis von Warren, Richard B, Blauvelt, Andrew, Bagel, Jerry, Papp, Kim A, Yamauchi, Paul, Armstrong, April, Langley, Richard G, Vanvoorden, Veerle, De Cuyper, Dirk, Cioffi, Christopher, Peterson, Luke, Cross, Nancy, Reich, Kristian

Volltext

Health related quality of life outcomes in cancer clinical trials von Bottomley, A., Flechtner, H., Efficace, F., Vanvoorden, V., Coens, C., Therasse, P., Velikova, G., Blazeby, J., Greimel, E.

Volltext

Three-dimensional echocardiography of the athlete’s heart: a comparison with cardiac magnetic resonance imaging von De Bosscher, Ruben, Claeys, Mathias, Dausin, Christophe, Goetschalckx, Kaatje, Claus, Piet, Herbots, Lieven, Ghekiere, Olivier, Van De Heyning, Caroline, Paelinck, Bernard P., Janssens, Kristel, Wright, Leah, Flannery, Michael Darragh, La Gerche, André, Willems, Rik, Heidbuchel, Hein, Bogaert, Jan, Claessen, Guido

Volltext

The challenges and achievements involved in implementing Quality of Life research in cancer clinical trials von Bottomley, A., Vanvoorden, V., Flechtner, H., Therasse, P.

Volltext

Bimekizumab versus secukinumab continuous maintenance of response at every visit through one year in patients with moderate to severe plaque psoriasis: Post-hoc results from the BE... von Warren, RB, Conrad, C, Foley, P, Iversen, L, Langley, RG, Kokolakis, G, Davis, L, Vanvoorden, V, Wiegratz, S, Merola, JF

Volltext

Bimekizumab Versus Ustekinumab in Plaque Psoriasis: Lasting Efficacy Translates to Rapid and Sustained Improvements in Quality of Life in the BE VIVID Multicenter, Randomized, Doub... von Gordon, K, Foley, P, Rich, P, Duffin, K, Pinter, A, Griffiths, CEM, Wang, M, Vanvoorden, V, Staelens, F, Ciaravino, V, Merola, JF

Volltext

Bimekizumab Safety in Patients with Moderate to Severe Psoriasis: Analysis of Pooled Data from Phase 2 and 3 Clinical Trials von Reich, K, Blauvelt, A, Lebwohl, M, Papp, KA, Rich, P, Strober, B, De Cuyper, D, Madden, C, Peterson, L, Vanvoorden, V, Warren, RB

Volltext

Efficacy and Safety of Bimekizumab in Patients with Moderate to Severe Plaque Psoriasis: Results from BE READY, a 56-Week Phase 3, Randomized, Double-Blinded, Placebo-Controlled St... von Gordon, K, Foley, P, Krueger, JG, Pinter, A, Reich, K, Vender, R, Vanvoorden, V, Madden, C, Peterson, L, Blauvelt, A

Volltext

Bimekizumab Efficacy and Safety versus Adalimumab in Patients with Moderate to Severe Plaque Psoriasis: Results from a Multicenter, Randomized, Double-Blinded Active Comparator-Con... von Warren, RB, Blauvelt, A, Bagel, J, Papp, KA, Yamauchi, P, Armstrong, A, Langley, R, Vanvoorden, V, De Cuyper, D, Peterson, L, Cross, N, Reich, K

Volltext